Cargando…

The Use of Glucocorticoids in Lupus Nephritis: New Pathways for an Old Drug

Glucocorticoids therapy has greatly improved the outcome of lupus nephritis patients. Since their discovery, their adverse effects have counterbalanced their beneficial anti-inflammatory effects. Glucocorticoids exert their effects through both genomic and non-genomic pathways. Differential activati...

Descripción completa

Detalles Bibliográficos
Autores principales: Mejía-Vilet, Juan M., Ayoub, Isabelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7921306/
https://www.ncbi.nlm.nih.gov/pubmed/33665199
http://dx.doi.org/10.3389/fmed.2021.622225
_version_ 1783658440333197312
author Mejía-Vilet, Juan M.
Ayoub, Isabelle
author_facet Mejía-Vilet, Juan M.
Ayoub, Isabelle
author_sort Mejía-Vilet, Juan M.
collection PubMed
description Glucocorticoids therapy has greatly improved the outcome of lupus nephritis patients. Since their discovery, their adverse effects have counterbalanced their beneficial anti-inflammatory effects. Glucocorticoids exert their effects through both genomic and non-genomic pathways. Differential activation of these pathways is clinically relevant in terms of benefit and adverse effects. Ongoing aims in lupus nephritis treatment development focus on a better use of glucocorticoids combined with immunosuppressant drugs and biologics. Newer regimens aim to decrease the peak glucocorticoid dose, allow a rapid glucocorticoid tapering, and intend to control disease activity with a lower cumulative glucocorticoid exposure. In this review we discuss the mechanisms, adverse effects and recent strategies to limit glucocorticoid exposure without compromising treatment efficacy.
format Online
Article
Text
id pubmed-7921306
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-79213062021-03-03 The Use of Glucocorticoids in Lupus Nephritis: New Pathways for an Old Drug Mejía-Vilet, Juan M. Ayoub, Isabelle Front Med (Lausanne) Medicine Glucocorticoids therapy has greatly improved the outcome of lupus nephritis patients. Since their discovery, their adverse effects have counterbalanced their beneficial anti-inflammatory effects. Glucocorticoids exert their effects through both genomic and non-genomic pathways. Differential activation of these pathways is clinically relevant in terms of benefit and adverse effects. Ongoing aims in lupus nephritis treatment development focus on a better use of glucocorticoids combined with immunosuppressant drugs and biologics. Newer regimens aim to decrease the peak glucocorticoid dose, allow a rapid glucocorticoid tapering, and intend to control disease activity with a lower cumulative glucocorticoid exposure. In this review we discuss the mechanisms, adverse effects and recent strategies to limit glucocorticoid exposure without compromising treatment efficacy. Frontiers Media S.A. 2021-02-16 /pmc/articles/PMC7921306/ /pubmed/33665199 http://dx.doi.org/10.3389/fmed.2021.622225 Text en Copyright © 2021 Mejía-Vilet and Ayoub. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Mejía-Vilet, Juan M.
Ayoub, Isabelle
The Use of Glucocorticoids in Lupus Nephritis: New Pathways for an Old Drug
title The Use of Glucocorticoids in Lupus Nephritis: New Pathways for an Old Drug
title_full The Use of Glucocorticoids in Lupus Nephritis: New Pathways for an Old Drug
title_fullStr The Use of Glucocorticoids in Lupus Nephritis: New Pathways for an Old Drug
title_full_unstemmed The Use of Glucocorticoids in Lupus Nephritis: New Pathways for an Old Drug
title_short The Use of Glucocorticoids in Lupus Nephritis: New Pathways for an Old Drug
title_sort use of glucocorticoids in lupus nephritis: new pathways for an old drug
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7921306/
https://www.ncbi.nlm.nih.gov/pubmed/33665199
http://dx.doi.org/10.3389/fmed.2021.622225
work_keys_str_mv AT mejiaviletjuanm theuseofglucocorticoidsinlupusnephritisnewpathwaysforanolddrug
AT ayoubisabelle theuseofglucocorticoidsinlupusnephritisnewpathwaysforanolddrug
AT mejiaviletjuanm useofglucocorticoidsinlupusnephritisnewpathwaysforanolddrug
AT ayoubisabelle useofglucocorticoidsinlupusnephritisnewpathwaysforanolddrug